Journal Article Summary
The article investigates the relationship between neutrophil count (NC) and outcomes in patients who have experienced an acute ischemic stroke or transient ischemic attack (TIA). This topic is significant because inflammation plays a crucial role in the progression of these conditions, and understanding how inflammatory markers like NC affect treatment outcomes can help improve patient care. The study specifically examines how different levels of NC influence the effectiveness and safety of dual antiplatelet therapy (clopidogrel combined with aspirin) compared to aspirin alone.
The research analyzed data from the INSPIRES trial, which included 5,929 patients with a median age of 65 years. Patients were categorized based on their NC into low, intermediate, and high groups. The findings revealed that those with a higher NC benefited more from the dual therapy, showing a reduced risk of stroke within 90 days compared to those receiving aspirin alone. Importantly, there was no significant increase in the risk of moderate-to-severe bleeding associated with the dual therapy across different NC levels, suggesting that the combination therapy is safe for patients with higher NC.
However, the study has limitations, including its reliance on NC as the sole inflammatory marker, which may not capture the full picture of systemic inflammation. Additionally, the research was conducted in a specific Chinese population, which may limit the applicability of the findings to other groups. Patients should discuss these results with their healthcare providers, especially regarding the implications of NC on treatment choices and the potential benefits and risks of dual antiplatelet therapy in the context of their individual health conditions.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Wang Yicong, Pan Yuesong, Wang Xuan, Gao Ying, Chen Weiqi, Johnston S. Claiborne, Bath Philip M., Amarenco Pierre, et al.. Relationship Between Neutrophil Count and 90‐Day Outcomes and Effect of Dual Antiplatelet Therapy in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the INSPIRES Trial. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2025. DOI: 10.1161/JAHA.124.040492. PMID: 40654232. PMCID: PMC12533628.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
